NASDAQ · NEPH
Nephros, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NEPH: Nov 5, 2026
Nephros, Inc. Common Stock is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $0.02. The reported EPS for the same quarter last year was $0.03.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.02 | $0.02 | $0.02 | 1 |
| Dec 2026 | $0.01 | $0.01 | $0.01 | 1 |
| Mar 2027 | $0.03 | $0.03 | $0.03 | 1 |
| Jun 2027 | $0.17 | $0.17 | $0.17 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Fintel · TipRanks- RTTNews · Aug 24, 10:07 PM EDT5 After-Hours Healthcare Gainers: AMIX, PMI, TENX, KURA, NEPH(RTTNews) – The after-hours gainers on Monday included Autonomix Medical, following its recent reverse stock split; Picard Medical, which reported encouraging Q2 results recently; and Tenax Therapeutics, now showing signs of recovery after plunging 90% earlier this month, among o
- The Motley Fool · Aug 13, 7:42 AM EDTNephros (NEPH) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- The Motley Fool · May 8, 4:10 PM EDTNephros (NEPH) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- The Motley Fool · Mar 13, 9:25 AM EDTNephros (NEPH) Q4 2025 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Fintel · Nov 17, 10:56 AM ESTNephros (NEPH) Price Target Increased by 27.27% to 7.14The average one-year price target for Nephros (NasdaqCM:NEPH) has been revised to $7.14 / share. This is an increase of 27.27% from the prior estimate of $5.61 dated November 7, 2025. The price target is an average of many targets provided by analysts. The lat
- RTTNews · Oct 14, 9:49 AM EDT13 Biotech Stocks Charging Ahead With New 52-week Highs – Will Near-term Catalysts Drive More Gains?(RTTNews) – "All there is to investing is picking good stocks at good times and staying with them as long as they remain good companies", said Warren Buffet, reminding us that patience and discipline are key to successful investing. Stocks quietly climbing to new 52-week highs co
- TipRanks · Oct 24, 9:10 AM EDTNephros launches HydraGuard 20″ UltraFilter
- Fintel · Nov 27, 9:13 AM ESTNephros (NEPH) Price Target Increased by 50.00% to 4.59The average one-year price target for Nephros (NASDAQ:NEPH) has been revised to 4.59 / share. This is an increase of 50.00% from the prior estimate of 3.06 dated October 31, 2023. The price target is an average of many targets provided by analysts. The latest
- Zacks · Nov 2, 6:25 PM EDTNephros Inc. (NEPH) Reports Q3 Loss, Misses Revenue EstimatesNephros Inc. (NEPH) came out with a quarterly loss of $0.12 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items.
- Zacks · Oct 27, 10:02 AM EDTLantheus Holdings (LNTH) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseThe market expects Lantheus Holdings (LNTH) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2022. This widely-known consensus outlook is important in assessing the company's earnings picture, but
- Zacks · Oct 26, 10:01 AM EDTWill Nephros Inc. (NEPH) Report Negative Earnings Next Week? What You Should KnowWall Street expects flat earnings compared to the year-ago quarter on lower revenues when Nephros Inc. (NEPH) reports results for the quarter ended September 2022. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful
- Zacks · Aug 10, 5:35 PM EDTNephros Inc. (NEPH) Reports Q2 Loss, Tops Revenue EstimatesNephros Inc. (NEPH) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Nephros, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.